{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-055990","form_type":"8-K","ticker":"KNSA","cik":"0001730430","company_name":"Kiniksa Pharmaceuticals International, plc","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.503611+00:00","generated_at":"2026-05-20T01:48:16.397842+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Kiniksa shareholders elect all director nominees and approve all 13 proposals at annual meeting","bullets":["All 10 director nominees elected; Stephen R. Biggar received 15.3M against votes, Felix J. Baker 12.3M against.","Say-on-pay (Prop 10) passed with 49.1M for, 550.7K against.","Authority to allot shares up to ~35% of share capital (Prop 11) passed: 41.2M for, 11.2M against.","Disapplication of pre-emption rights (Prop 12) passed: 40.7M for, 11.7M against.","Preference share redemption to create distributable reserves (Prop 13) passed with 52.4M for, 23.2K against."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-055990","json":"https://secwatch.observer/filing/0001104659-25-055990.json","markdown":"https://secwatch.observer/filing/0001104659-25-055990.md","text":"https://secwatch.observer/filing/0001104659-25-055990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730430/000110465925055990/0001104659-25-055990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730430/000110465925055990/tm2517053d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:48:16.397842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}